Mediphar Labs. has launched DOLFEIN® tablet in March 2018 in the Lebanese market.

DOLFEIN® is indicated for the symptomatic treatment of moderate to severe pain.


We are proud to be introducing this medicament into the market, providing patients with a new and effective treatment option for pain not responding for peripheral analgesic alone.

Back to All News
We care about your questions and concerns. Please call the consumer healthcare service:
+961 4 540056 or by email: chs@medipharlabs.com